Nxera Pharma Webinar Presentation for FY2025 Financial Results
Tokyo, Japan and Cambridge, UK, 26 January 2026 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for the year ended 31 December 2025 on Friday, 13 February 2026.
The Company will host a live webinar presentation with Chris Cargill, President and CEO, Hironoshin Nomura, CFO, Patrik Foerch CSO and President of Nxera Pharma UK and Toshi Maeda, COO and President of Nxera Pharma Japan, at 5:00 pm JST (8:00 am GMT) on Friday, 13 February 2026.
The webinar is open to all existing and potential investors as well as sell-/buy-side analysts and will consist of a presentation followed by a Q&A session. Please click here to pre-register, which will provide a link to access the webinar.
Presentation slides will be made available by 4:30 pm JST (7:30 am GMT) on 13 February 2026 through the investor section of the Company’s Home Page here.